Tech Company Financing Transactions

Tengion Funding Round

Tengion closed a $5.3 million venture capital round on 3/31/2005. Backers included Healthcap Venture Capital, Johnson & Johnson Development Corporation and Oak Investment Partners.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

3929 Westpoint Blvd. G
Winston-Salem, NC 27103
USA

Phone

(336) 722-5855

Website

www.tengion.com

Email Address

[email protected]

Overview

Tengion (NASDAQ: TNGN) is a leader in developing autologous neo-organs and tissues, such as bladders, that are derived from the patient's own (autologous) cells.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

John Miclot

        

Chief Financial Officer

Brian Davis

        

Chief Scientific Officer

Tim Bertram

        

Chief Technical Officer

Deepak Jain

        

Browse more venture capital transactions:

Prev: 3/31/2005: PerfectServe venture capital transaction
Next: 3/31/2005: ExteNet Systems venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary